Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors

Radionuclides are needed both for nuclear medicine imaging as well as for peptide-receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NET). Imaging is important in the initial diagnostic work-up and for staging NETs. In therapy planning, somatostatin receptor imaging (SRI) is used when tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjaer, Andreas, Knigge, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487540/
https://www.ncbi.nlm.nih.gov/pubmed/25959100
http://dx.doi.org/10.3109/00365521.2015.1033454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487540/
https://www.ncbi.nlm.nih.gov/pubmed/25959100
http://dx.doi.org/10.3109/00365521.2015.1033454

Ejemplares similares